Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-10-23	HK$0.1820	-0.55%	0
26-10-22	HK$0.1830	0.00%	24,000
26-10-21	HK$0.1830	0.00%	24,000
26-10-20	HK$0.1830	+5.17%	126,000
26-10-16	HK$0.1740	-7.94%	708,000

Delayed Quote Hong Kong S.E.

More quotes

Market Closed - Hong Kong S.E. 04:08:09 2026-10-23 EDT			5-day change	1st Jan Change
0.1820 ^HKD	-0.55%		+4.60%	-31.32%

09-21	Meilleure Health to Acquire Property Investment Company	MT
09-20	Meilleure Health International Industry Group Limited agreed to acquire Tech-Medi Development Limited from Zhou Xuzhou for HKD 35.2 million.	CI

Market Cap	738M 94.12M 84.05M 77.64M 70.36M 132M 8.93B 134M 934M 370M 4.68B 353M 346M 14.76B	P/E 2024	36.7x	P/E 2025	28.5x
Enterprise Value	1.11B 141M 126M 116M 105M 197M 13.39B 201M 1.4B 554M 7.01B 529M 518M 22.11B	EV / Sales 2024	28.8x	EV / Sales 2025	39.6x
Free-Float	30.87%	Yield 2024	1.38%	Yield 2025	2.08%

09-21	Meilleure Health to Acquire Property Investment Company	MT
09-20	Meilleure Health International Industry Group Limited agreed to acquire Tech-Medi Development Limited from Zhou Xuzhou for HKD 35.2 million.	CI
08-27	Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-27	Meilleure Health International Industry Group Limited Announces Interim (Semi-Annual) Ordinary Cash Dividend for the Six Months Ended 30 June 2026, Payable on 30 September 2026	CI
07-22	Meilleure Health International Industry Group Limited Announces Change of Registered Office Address in Hamilton	CI
07-07	Meilleure Health Forecasts Rise in H1 Profit	MT
07-07	Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2026	CI
06-26	Meilleure Health International Industry Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2025	CI
03-27	Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Meilleure Health International Industry Group Limited Recommends Payment of Final Dividend for the Year Ended December 31, 2025, Payable on August 28, 2026	CI
01-08	Meilleure Health to Acquire Chinese Property Leasing Firm for HK$137 Million	MT
01-08	Meilleure Health International Industry to buy Jiangsu Yide for RMB124.8 million	RE
01-07	Meilleure Health International Industry Group Limited signed a Equity Interest Transfer Agreement to acquire Jiangsu Yide Investment Company Limited from Zhou Chuan and Tan Wensheng for approximately CNY 120 million.	CI

21-04-22	Meilleure Health International Industry : GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; RE-ELECTION OF DIRECTORS; CLOSURE OF REGISTER OF MEMBERS; AND NOTICE OF ANNUAL GENERAL MEETING	PU
21-04-22	PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 24 JUNE 2021 AT 11:00 A.M. AND ANY ADJOURNMENT THEREOF	PU
20-09-15	Meilleure Health International Industry : (1) REVISION OF ANNUAL CAP OF CONTINUING CONNECTED TRANSACTIONS FOR THE YEAR ENDING 31 DECEMBER 2020; AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO RENEWAL OF FRAMEWORK AGREEMENT	PU
20-08-16	Meilleure Health International Industry : INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020	PU
20-03-15	Meilleure Health International Industry : PROFIT WARNING	PU

Meilleure Health International Industry Group Limited Stock

Stocks

2327

BMG5975D1048

Pharmaceuticals

Valuation: Meilleure Health International Industry Group Limited

Chart: Meilleure Health International Industry Group Limited

Latest news: Meilleure Health International Industry Group Limited

Press Releases: Meilleure Health International Industry Group Limited

Quotes and Performance

Price Extremes

Managers and Directors: Meilleure Health International Industry Group Limited

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 day	-0.55%
1 week	+4.60%
Current month	-19.82%
1 month	-20.87%
3 months	-27.20%
6 months	-36.14%
Current year	-31.32%

1 week	0.16	0.18
1 month	0.16	0.23
Current year	0.16	0.3
1 year	0.16	0.3
3 years	0.11	0.32
5 years	0.11	0.48
10 years	0.11	1.64

Manager	Title	Age	Since
Wen Chuan Zhou CEO	Chief Executive Officer	43	2013-08-29
Kwai Kwan Tsoi SEC	Corporate Secretary	34	2025-12-30
Mei Yi Chu SEC	Corporate Secretary	33	2025-12-30

Director	Title	Age	Since
Xu Zhou Zhou CHM	Chairman	70	2013-08-29
Wen Chuan Zhou BRD	Director/Board Member	43	2013-08-29
Chi Wai Chau BRD	Director/Board Member	64	2013-08-29

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/11/26	Xu Zhou Zhou	Other	Chairman	840,000	0.0207%
7/14/26	Xu Zhou Zhou	Other	Chairman	780,000	0.0192%
7/8/26	Wen Chuan Zhou	Other	Chief Executive Officer	240,000	0.0059%

	2024	2025
Net sales	50.68M 6.46M 5.77M 5.33M 4.83M 9.04M 613M 9.19M 64.15M 25.4M 321M 24.25M 23.74M 1.01B	36.52M 4.66M 4.16M 3.84M 3.48M 6.51M 442M 6.62M 46.23M 18.3M 232M 17.48M 17.1M 730M
Net income	32.48M 4.14M 3.7M 3.42M 3.1M 5.79M 393M 5.89M 41.12M 16.28M 206M 15.54M 15.21M 649M	37.98M 4.84M 4.33M 4M 3.62M 6.77M 460M 6.89M 48.08M 19.04M 241M 18.18M 17.79M 759M
Net Debt	273M 34.83M 31.1M 28.73M 26.04M 48.71M 3.31B 49.52M 346M 137M 1.73B 131M 128M 5.46B	368M 46.91M 41.89M 38.7M 35.07M 65.61M 4.45B 66.7M 466M 184M 2.33B 176M 172M 7.36B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED	-0.55%	+4.60%	-35.00%	-28.63%	94.12M
ELI LILLY AND COMPANY	-2.54%	+1.31%	+54.27%	+114.96%	1,135B
JOHNSON & JOHNSON	-1.42%	+3.23%	+38.56%	+74.44%	635B
ABBVIE INC.	+0.16%	+0.08%	+25.29%	+95.23%	505B
ROCHE HOLDING AG	-0.31%	+3.09%	+44.14%	+64.80%	378B
MERCK & CO., INC.	-1.34%	-0.47%	+66.04%	+41.00%	358B
NOVARTIS AG	-0.68%	+2.65%	+22.98%	+50.39%	295B
ASTRAZENECA PLC	-1.20%	+3.04%	+2.33%	+22.86%	266B
AMGEN INC.	-1.79%	+1.57%	+50.56%	+59.08%	237B
GILEAD SCIENCES, INC.	-0.73%	-0.10%	+29.02%	+99.67%	193B
Average	-1.04%	+2.41%	+29.82%	+59.38%	400.38B
Weighted average by Cap.	-1.35%	+2.66%	+41.02%	+79.75%